AAPL   320.07 (+0.62%)
MSFT   181.85 (+0.02%)
AMZN   2,416.57 (+0.26%)
NVDA   347.52 (+1.91%)
CGC   21.32 (+7.14%)
BABA   199.36 (-0.90%)
MU   47.90 (-3.13%)
GE   7.09 (-2.74%)
TSLA   820.15 (+-0.01%)
AMD   52.95 (+0.38%)
T   31.44 (-1.29%)
ACB   16.49 (+7.78%)
F   5.91 (-1.99%)
NFLX   416.82 (-0.73%)
BAC   25.32 (-2.54%)
BA   153.87 (+2.91%)
AAPL   320.07 (+0.62%)
MSFT   181.85 (+0.02%)
AMZN   2,416.57 (+0.26%)
NVDA   347.52 (+1.91%)
CGC   21.32 (+7.14%)
BABA   199.36 (-0.90%)
MU   47.90 (-3.13%)
GE   7.09 (-2.74%)
TSLA   820.15 (+-0.01%)
AMD   52.95 (+0.38%)
T   31.44 (-1.29%)
ACB   16.49 (+7.78%)
F   5.91 (-1.99%)
NFLX   416.82 (-0.73%)
BAC   25.32 (-2.54%)
BA   153.87 (+2.91%)
AAPL   320.07 (+0.62%)
MSFT   181.85 (+0.02%)
AMZN   2,416.57 (+0.26%)
NVDA   347.52 (+1.91%)
CGC   21.32 (+7.14%)
BABA   199.36 (-0.90%)
MU   47.90 (-3.13%)
GE   7.09 (-2.74%)
TSLA   820.15 (+-0.01%)
AMD   52.95 (+0.38%)
T   31.44 (-1.29%)
ACB   16.49 (+7.78%)
F   5.91 (-1.99%)
NFLX   416.82 (-0.73%)
BAC   25.32 (-2.54%)
BA   153.87 (+2.91%)
AAPL   320.07 (+0.62%)
MSFT   181.85 (+0.02%)
AMZN   2,416.57 (+0.26%)
NVDA   347.52 (+1.91%)
CGC   21.32 (+7.14%)
BABA   199.36 (-0.90%)
MU   47.90 (-3.13%)
GE   7.09 (-2.74%)
TSLA   820.15 (+-0.01%)
AMD   52.95 (+0.38%)
T   31.44 (-1.29%)
ACB   16.49 (+7.78%)
F   5.91 (-1.99%)
NFLX   416.82 (-0.73%)
BAC   25.32 (-2.54%)
BA   153.87 (+2.91%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacira BiosciencesCorcept TherapeuticsSAGE TherapeuticsCytoDynDicerna Pharmaceuticals
SymbolNASDAQ:PCRXNASDAQ:CORTNASDAQ:SAGEOTCMKTS:CYDYNASDAQ:DRNA
Price Information
Current Price$44.72$16.00$37.82$2.98$21.25
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.31.61.31.7
Analysis Score3.32.34.33.54.5
Community Score2.92.73.12.53.0
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.00.01.0
Earnings & Valuation Score1.90.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$54.50$17.67$82.11$4.00$34.20
% Upside from Price Target21.87% upside10.42% upside117.11% upside34.23% upside60.94% upside
Trade Information
Market Cap$1.88 billion$1.74 billion$2.03 billion$1.52 billion$1.51 billion
Beta1.311.12.75-0.541.84
Average Volume574,485955,629984,0075,463,990621,838
Sales & Book Value
Annual Revenue$421.03 million$306.49 million$6.87 millionN/A$23.90 million
Price / Sales4.475.98285.82N/A65.72
Cashflow$1.73 per share$0.87 per shareN/AN/AN/A
Price / Cash25.7918.44N/AN/AN/A
Book Value$8.88 per share$3.57 per share$16.36 per share($0.03) per share$2.41 per share
Price / Book5.044.482.31N/A8.82
Profitability
Net Income$-11,020,000.00$94.18 million$-680,240,000.00$-56,190,000.00$-120,460,000.00
EPS$0.86$0.77($13.38)($0.21)($1.76)
Trailing P/E RatioN/A18.18N/AN/AN/A
Forward P/E Ratio23.1729.09N/A8.05N/A
P/E Growth$1.49N/AN/AN/AN/A
Net Margins-0.02%31.64%-7,406.75%N/A-213.04%
Return on Equity (ROE)13.89%30.00%-63.13%N/A-74.79%
Return on Assets (ROA)6.06%27.29%-56.60%-293.70%-22.53%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.94%N/A0.03%N/A0.12%
Current Ratio5.37%10.12%12.77%0.60%2.90%
Quick Ratio4.63%9.97%12.77%0.21%2.90%
Ownership Information
Institutional Ownership PercentageN/A76.15%N/A0.08%82.78%
Insider Ownership Percentage5.80%15.50%4.80%11.80%21.28%
Miscellaneous
Employees518166637678
Shares Outstanding42.12 million114.60 million51.92 million510.32 million73.92 million
Next Earnings Date8/13/2020 (Estimated)8/6/2020 (Estimated)8/4/2020 (Estimated)8/12/2020 (Estimated)8/13/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.